Neurogesx (NGSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 11,500 | 0 | 0 | 0 | 0 |
| Cost of Goods | 680 | N/A | N/A | 0 | 0 |
| Gross Profit | 10,810 | N/A | N/A | 0 | 0 |
| Operating Expenses | 49,960 | 0 | 0 | 26,280 | 32,770 |
| Operating Income | -39,140 | N/A | N/A | -26,280 | -32,770 |
| Interest Expense | 10,400 | 0 | 0 | 790 | 1,210 |
| Other Income | 0 | 0 | 0 | 1,040 | 2,030 |
| Pre-tax Income | -49,540 | 0 | 0 | -26,030 | -31,950 |
| Net Income Continuous | -49,545 | N/A | N/A | -26,035 | -31,956 |
| Net Income | $-49,540 | $N/A | $N/A | $-26,030 | $-31,950 |
| EPS Basic Total Ops | -2.15 | N/A | N/A | -1.49 | -4.06 |
| EPS Basic Continuous Ops | -2.15 | N/A | N/A | -1.49 | -3.54 |
| EPS Diluted Total Ops | -2.15 | N/A | N/A | -1.49 | -4.06 |
| EPS Diluted Continuous Ops | -2.15 | N/A | N/A | -1.49 | -3.54 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.51 | -1.24 | N/A | N/A |
| EBITDA(a) | $-37,470 | $N/A | $N/A | $-25,910 | $-32,490 |